Results 121 to 130 of about 41,992 (300)
New Horizons for Multiple Sclerosis Therapy: 2025 and Beyond. [PDF]
The advances achieved against multiple sclerosis (MS) represent one of the great success stories of modern molecular medicine. The development of therapies with increasing selectivity and safety, guided by gains in understanding the fundamental immunology, neurobiology, genetics, and triggers of this disease, have broadened the traditional focus on ...
Sabatino JJ, Cree BAC, Hauser SL.
europepmc +2 more sources
The adult oligodendrocyte can participate in remyelination
Significance Remyelination of the CNS is a critical process in restoring function and protecting nerve fibers from degeneration in multiple sclerosis and other demyelinating diseases.
I. Duncan+5 more
semanticscholar +1 more source
Targeting CXCR7/ACKR3 as a therapeutic strategy to promote remyelination in the adult central nervous system [PDF]
Current treatment modalities for the neurodegenerative disease multiple sclerosis (MS) use disease-modifying immunosuppressive compounds but do not promote repair. Although several potential targets that may induce myelin production have been identified,
Arnett+35 more
core +2 more sources
Importance of R2 accuracy in susceptibility source separation
Abstract Purpose To examine the importance of R2 accuracy on independent paramagnetic and diamagnetic outputs from susceptibility source separation in the brain from two publicly available methods. Methods The effects of R2 errors, which translate into R2′$$ {\mathrm{R}}_2^{\prime } $$ errors, on output maps from χ‐separation and χ‐sepnet were examined
Tereza Beatriz Oliveira Assunção+6 more
wiley +1 more source
Activation of oligodendroglial Stat3 is required for efficient remyelination
Multiple sclerosis is the most prevalent demyelinating disease of the central nervous system (CNS) and is histologically characterized by perivascular demyelination as well as neurodegeneration.
Andrew J. Steelman+6 more
doaj +1 more source
Impaired oligodendrocyte (OL) differentiation and remyelination after myelin damage in multiple sclerosis is associated with neurodegeneration. The authors show that Gsta4 is expressed during adult OL differentiation and identify it as a regulator of OL ...
Karl E. Carlström+8 more
doaj +1 more source
Temporal and partial inhibition of GLI1 in neural stem cells (NSCs) results in the early maturation of NSC derived oligodendrocytes in vitro. [PDF]
BackgroundOligodendrocytes are a type of glial cells that synthesize the myelin sheath around the axons and are critical for the nerve conduction in the CNS.
Biswas, Sangita+5 more
core
Phytochemical Nanoparticles for the Treatment of Neurological Disorders
ABSTRACT Neurological disorders impose a significant burden on the healthcare systems. The latest published data by WHO indicated that stroke was the second leading cause of death globally in 2020, with Alzheimer's disease (AD) and other dementias in the seventh position.
Touraj Ehtezazi, Satyajit D. Sarker
wiley +1 more source
Demyelination in vascular dementia (VD) is partly attributable to inflammation induced by chronic cerebral hypoperfusion (CCH). Remyelination contributes to the recovery of cognitive impairment by inducing the proliferation and differentiation of ...
Meixi Li+7 more
semanticscholar +1 more source
Galectin-3-mediated glial crosstalk drives oligodendrocyte differentiation and (Re)myelination [PDF]
Galectin-3 (Gal-3) is the only chimeric protein in the galectin family. Gal-3 structure comprises unusual tandem repeats of proline and glycine-rich short stretches bound to a carbohydrate-recognition domain (CRD).
Pasquini, Laura Andrea, Thomas, Laura
core +1 more source